Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer.
Andreas SeeberFrancesca BattaglinKai ZimmerFlorian KocherYasmine BacaJoanne XiuGilbert SpizzoVeronica Novotny-DiermayrDietmar RiederAlberto PucciniJeff SwensenMichelle EllisRichard M GoldbergAxel GrotheyAnthony Frank ShieldsJohn L MarshallBenjamin A WeinbergPaul E SacksteinKiat Hon LimGek San TanChadi NabhanWolfgang Michael KornArno AmannZlatko TrajanoskiMartin D BergerEmil LouDominik WolfHeinz-Josef LenzPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
This is the largest series of RSPOfp/RNF43-mut colorectal cancers reported to date. Comprehensive molecular analyses asserted the unique molecular landscape associated with RSPO/RNF43 and suggested potential alternative strategies to overcome the low clinical impact of Wnt-targeted agents and immunotherapy.